HKG:3320 Revenue

China Resources Pharmaceutical Group had revenue of 131.87B CNY in the half year ending June 30, 2025, with 7.37% growth. This brings the company's revenue in the last twelve months to 260.94B, up 4.18% year-over-year. In the year 2024, China Resources Pharmaceutical Group had annual revenue of 257.67B with 5.30% growth.

Revenue (ttm)

260.94B CNY

Revenue Growth

+4.18%

P/S Ratio

0.11

Revenue / Employee

3.59M CNY

Employees

72,700

Market Cap

31.35B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	257.67B	12.97B	5.30%
Dec 31, 2023	244.70B	26.52B	12.16%
Dec 31, 2022	218.18B	25.26B	13.10%
Dec 31, 2021	192.92B	24.16B	14.31%
Dec 31, 2020	168.76B	-14.00B	-7.66%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
JD Health International	71.34B
BeOne Medicines AG	35.81B
Sino Biopharmaceutical	33.49B
Alibaba Health Information Technology	32.81B
CSPC Pharmaceutical Group	28.49B
WuXi Biologics	21.98B
Hansoh Pharmaceutical Group Company	14.45B
Innovent Biologics	12.52B

Revenue Rankings

China Resources Pharmaceutical Group News

1 year ago - Health product chain store CR Care to close all 19 branches in Hong Kong in November - Hong Kong Free Press

More News